Screening for HIV in pregnant women: systematic review to update the U.S. Preventive Services Task Force Recommendation.
Chou R, Cantor A, Bougatsos C, Zakher B
Record ID 32013000759
English
Authors' objectives:
To systematically update the 2005 USPSTF review on benefits and harms of prenatal HIV screening, focusing on research gaps previously identified and new evidence on treatments.
Authors' recommendations:
Antiretroviral therapy in combination with avoidance of breastfeeding and elective Cesarean delivery in women with viremia reduces risk of mother-to-child transmission. Use of certain antiretroviral therapy regimens during pregnancy may increase risk of preterm delivery, but more evidence is needed to fully understand short- and long-term maternal and infant effects.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.ncbi.nlm.nih.gov/books/NBK114880/pdf/TOC.pdf
URL for additional information:
http://www.ncbi.nlm.nih.gov/books/NBK114880/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Anxiety
- False Positive Reactions
- Female
- Pregnancy
- Pregnancy Outcome
- Risk Assessment
- United States
- Anti-Retroviral Agents
- HIV Infections
- Infectious Disease Transmission, Vertical
- Mass Screening
- Pregnancy Complications, Infectious
- Prenatal Diagnosis
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.